Dividend Assets Capital, LLC T2 Biosystems, Inc. Transaction History

Dividend Assets Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$0.09 - $565.0 $90 - $565,000	-1,000 Reduced 20.0%	4,000 $0
Q1 2021 Apr 28, 2021	BUY	$1.32 - $3.79 $1,320 - $3,790	1,000 Added 25.0%	5,000 $8,000
Q4 2020 Jan 22, 2021	BUY	$1.06 - $1.51 $4,240 - $6,040	4,000 New	4,000 $5,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Dividend Assets Capital, LLC with notifications on news.